3 Reasons Why Growth Investors Shouldn't Overlook Privia Health (PRVA)
How Much Upside is Left in Privia Health (PRVA)? Wall Street Analysts Think 29.22%
PRVA Q3 2026 deep dive: acquisitions and provider growth drive expansion, profitability lags expectations
Privia Health Group, Inc. 2026 Q3 - Results - Earnings Call Presentation
Privia Health Group Q3 Earnings Call Highlights
Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $33
Piper Sandler Maintains Overweight on Privia Health Gr, Raises Price Target to $38
Why Privia Health Group (PRVA) Could Be 24% Undervalued Following Its Earnings Beat
Privia Health (PRVA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Privia Health Group, Inc. (PRVA) Q3 2026 Earnings Call Transcript
Privia Health: Q3 Earnings Snapshot
Privia Health (NASDAQ:PRVA) posts better-than-expected sales in Q3 2026, guides for strong full-year sales
Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results
Privia Health Gr Q3 2026 Earnings Call Transcript
Privia Health Gr Raises FY2026 Sales Guidance from $2.350B-$2.450B to $2.500B-$2.550B vs $2.457B Est
Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business
Privia Health Group Acquires American Choice Healthcare MSSP For ~$36M
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
Full Transcript: Privia Health Gr Q2 2026 Earnings Call
Why Privia Health Group (PRVA) Is Getting Attention Now
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.